Result Summary for 102130
| Protocol ID: | 102130 |
| Clinical Study ID: | AVS102130 |
| Official Title: | An Open-Label, Randomized, Four-Period Crossover Study in Healthy Subjects to Demonstrate the Bioequivalence of a Fixed Dose Combination Tablet Formulation of Rosiglitazone and Simvastatin (8mg/80mg) to Concomitant Dosing of Rosiglitazone 8mg and Simvastatin 80mg Commercial Tablets and to Assess ... |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | rosiglitazone/simvastatin |
| Trade/Product Name: | Avandastat |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
